Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abatacept with Ixazomib and Dexamethasone in Multiple Myeloma
NCT03457142Phase 2Terminated
- Sponsor
- Roswell Park Comprehensive Cancer Center
- Start
- Sep 2018
- Primary completion
- Nov 2022
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of abatacept in multiple myeloma (MM), sponsored by Roswell Park Comprehensive Cancer Center. Started Sep 2018; status: terminated.
02
Drugs
abatacept
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT03457142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03457142.